Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 6 |
List of Tables | 5 | 2 |
List of Figures | 7 | 1 |
Allergan Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 7 | 2 |
Allergan Plc, Medical Equipment Deals By Type, 2010 to YTD 2016 | 9 | 1 |
Allergan Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 10 | 1 |
Allergan Plc, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 11 | 1 |
Allergan Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 12 | 4 |
Allergan Plc, Medical Equipment, Deal Details | 16 | 72 |
Asset Purchase | 16 | 1 |
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics | 16 | 1 |
Allergan Acquires Distribution Business In Turkey For US$36.7 Million | 17 | 1 |
Venture Financing | 18 | 1 |
Oculeve Raises US$17 Million In Venture Financing | 18 | 1 |
AqueSys Raises US$43.6 Million In Series D Financing | 19 | 2 |
Anterios Raises US$8.5 Million In Venture Financing | 21 | 2 |
Anterios Raises US$4.7 Million In Venture Financing | 23 | 1 |
Oculeve Raises US$7.6 Million In Venture Financing | 24 | 1 |
Topokine Therapeutics Raises Funds Through Venture Financing | 25 | 1 |
Oculeve Raises Additional US$0.2 Million In Venture Financing | 26 | 1 |
Uteron Pharma Raises US$10.4 Million In Venture Financing | 27 | 1 |
AqueSys Raises US$12 Million In Venture Financing | 28 | 1 |
Uteron Pharma Raises US$19 Million In Venture Financing | 29 | 2 |
KYTHERA BioPharma Secures US$37.42 Million In Series D Financing Round | 31 | 2 |
Anterios Secures US$3.1 Million In Venture Financing | 33 | 1 |
Anterios Raises US$2 Million In Venture Financing | 34 | 1 |
AqueSys Secures US$35 Million In Series C Financing Round | 35 | 2 |
Anterios Raises US$1.5 Million In Venture Financing | 37 | 1 |
Private Equity | 38 | 1 |
TPG Capital Acquires Aptalis Pharma from Actavis | 38 | 1 |
SRIW Invests US$2 Million In Uteron Pharma | 39 | 1 |
Saffelberg Invests In Uteron Pharma | 40 | 1 |
Partnerships | 41 | 1 |
Medicines360 Enters Into Licensing Agreement With Actavis For Intrauterine Device | 41 | 2 |
Enzymatica To Enter Into Licensing Agreement With Actavis For ColdZyme Mouth Spray | 43 | 1 |
Acton Pharma Enters Into Licensing Agreement With Forest Labs | 44 | 1 |
Allergan Development Agreement with SonarMD | 45 | 1 |
Syneron Medical and Allergan Enter into Agreement | 46 | 1 |
Activaero Enters Into Collaboration With Forest Healthcare | 47 | 1 |
Equity Offering | 48 | 1 |
Anterios Postpones IPO for up to USD54.6 Million | 48 | 1 |
Actavis Raises USD5.06 Billion in Public Offering of Preferred Shares | 49 | 2 |
Actavis Raises USD4.18 Billion in Public Offering of Shares | 51 | 2 |
Forest Labs Plans Rights Offering Of Common Stock | 53 | 1 |
Debt Offering | 54 | 1 |
Forest Lab Completes Private Placement Of Notes Due 2019 For US$1.05 Billion | 54 | 1 |
Forest Lab Completes Private Placement Of Notes Due 2021 For US$750 Million | 55 | 1 |
Forest Labs Completes Private Placement Of Notes Due 2021 For US$1.2 Billion | 56 | 1 |
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million | 57 | 2 |
Asset Transactions | 59 | 1 |
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million | 59 | 2 |
Acquisition | 61 | 1 |
Allergan to Acquire Tobira Therapeutics in Tender Offer | 61 | 3 |
Allergan and Pfizer Terminate USD160 Billion Deal | 64 | 3 |
Allergan Acquires AqueSys | 67 | 1 |
Allergan Acquires Northwood Medical | 68 | 1 |
Allergan Acquires Oculeve | 69 | 1 |
Actavis Acquires Allergan for USD70.5 Billion | 70 | 2 |
Actavis Completes Acquisition of Forest Labs for USD28 Billion | 72 | 2 |
Forest Lab Completes Acquisition Of Aptalis Pharma From TPG Capital For US$2.9 Billion | 74 | 2 |
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion | 76 | 1 |
Actavis Completes Acquisition Of Remaining 26.7% Stake In Zdravlje For Up To US$9.1 Million | 77 | 1 |
Watson Pharma Acquires Uteron Pharma, Women's Health Company, For Up To US$305 Million | 78 | 2 |
SkinMedica Acquires Colorescience, Maker Of Skincare Products | 80 | 1 |
Allergan Acquires Precision Light For US$17.9 Million | 81 | 1 |
Allergan Completes Acquisition Of Alacer Biomedical | 82 | 1 |
Forest Labs Completes Acquisition Of Clinical Data | 83 | 3 |
Allergan Completes Acquisition Of Serica Technologies | 86 | 2 |
Allergan Plc - Key Competitors | 88 | 1 |
Key Employees | 89 | 2 |
Locations And Subsidiaries | 91 | 9 |
Head Office | 91 | 1 |
Other Locations &Subsidiaries | 91 | 9 |
Recent Developments | 100 | 1 |
Strategy And Business Planning | 100 | 1 |
Aug 09, 2016: EDA Board Acts to Encourage Global Pharmaceutical Company Allergan to Expand in New Jersey | 100 | 1 |
Oct 02, 2015: Allergan and Humana Announce Research Partnership to Improve Health Outcomes | 101 | 1 |
Financial Announcements | 102 | 1 |
Aug 08, 2016: Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion | 102 | 4 |
May 10, 2016: Allergan Reports Strong First Quarter 2016 Continuing Operations Performance with 48% Increase in Net Revenue to $3.8 Billion and 15% Growth in Non-GAAP Diluted EPS to $3.04 | 106 | 3 |
Corporate Communications | 109 | 1 |
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction | 109 | 1 |
Product News | 110 | 1 |
Mar 03, 2016: Allergan Launches Bold Access To LILETTA (levonorgestrel-releasing intrauterine system) | 110 | 1 |
Apr 28, 2015: Actavis and Medicines360 Announce Publication of ACCESS IUS Efficacy and Safety Study of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 mg in Contraception | 111 | 1 |
Other Significant Developments | 112 | 1 |
Oct 13, 2016: Allergan Partners with SonarMD to Develop Innovative IBS-D Patient Engagement Platform for Better Identification and Care of IBS-D Patients | 112 | 1 |
Oct 05, 2016: New Study Showcases Economic Impact of Allergan's Operations on New Jersey Economy | 113 | 2 |
Appendix | 115 | 1 |
Methodology | 115 | 1 |
About GlobalData | 115 | 1 |
Contact Us | 115 | 1 |
Disclaimer | 115 | 1 |